These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

156 related articles for article (PubMed ID: 6807700)

  • 1. Inhibition of lens and cataract aldose reductase by protein-bound anti-rheumatic drugs: salicylate, indomethacin, oxyphenbutazone, sulindac.
    Sharma YR; Cotlier E
    Exp Eye Res; 1982 Jul; 35(1):21-7. PubMed ID: 6807700
    [No Abstract]   [Full Text] [Related]  

  • 2. Inhibition of human lens aldose reductase by flavonoids, sulindac and indomethacin.
    Chaudhry PS; Cabrera J; Juliani HR; Varma SD
    Biochem Pharmacol; 1983 Jul; 32(13):1995-8. PubMed ID: 6409111
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The inhibition of bovine lens aldose reductase by Clinoril, its absorption into the human red cell and its effect on human red cell aldose reductase activity.
    Crabbe MJ; Freeman G; Halder AB; Bron AJ
    Ophthalmic Res; 1985; 17(2):85-9. PubMed ID: 3920599
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Differences in the susceptibility of various aldose reductases to inhibition. II.
    Kador PF; Kinoshita JH; Tung WH; Chylack LT
    Invest Ophthalmol Vis Sci; 1980 Aug; 19(8):980-2. PubMed ID: 6773903
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Diabetic complications in lens and nerve and their prevention by sulindac or sorbinil: two novel aldose reductase inhibitors.
    Jacobson M; Sharma YR; Cotlier E; Hollander JD
    Invest Ophthalmol Vis Sci; 1983 Oct; 24(10):1426-9. PubMed ID: 6413448
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Inhibition of aldose reductase by 3',4'-dihydroxyflavones.
    Okuda J; Miwa I; Inagaki K; Horie T; Nakayama M
    Chem Pharm Bull (Tokyo); 1984 Feb; 32(2):767-72. PubMed ID: 6428761
    [No Abstract]   [Full Text] [Related]  

  • 7. The effect of aldose reductase and its inhibition on sugar cataract formation.
    Kador PF; Akagi Y; Kinoshita JH
    Metabolism; 1986 Apr; 35(4 Suppl 1):15-9. PubMed ID: 3083204
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Inhibition of lens-aldose reductase activity by brazilin and haematoxylin.
    Moon CK; Yun YP; Lee JH; Wagner H; Shin YS
    Planta Med; 1985 Feb; (1):66-7. PubMed ID: 3925476
    [No Abstract]   [Full Text] [Related]  

  • 9. Inhibition of rat lens aldose reductase by bendazac-L-lysine salt.
    Iuliano G; Menzione M; Apponi-Battini G; Costagliola C
    Enzyme; 1989; 42(4):235-7. PubMed ID: 2517113
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Inhibition of aldose reductases from rat and bovine lenses by hydantoin derivatives.
    Inagaki K; Miwa I; Yashiro T; Okuda J
    Chem Pharm Bull (Tokyo); 1982 Sep; 30(9):3244-54. PubMed ID: 6816474
    [No Abstract]   [Full Text] [Related]  

  • 11. Irreversible aldose reductase inhibitors.
    Kador PF; Gurley RC; Ares JJ; Miller DD
    Prog Clin Biol Res; 1987; 232():353-65. PubMed ID: 3112788
    [No Abstract]   [Full Text] [Related]  

  • 12. Inhibition of lens aldose reductase by Labiatae flavonoids.
    Tomás-Barberán FA; López-Gómez C; Villar A; Tomás-Lorente F
    Planta Med; 1986 Jun; (3):239-40. PubMed ID: 3092256
    [No Abstract]   [Full Text] [Related]  

  • 13. Aldose reductase in diabetic cataracts.
    Kinoshita JH; Kador P; Catiles M
    JAMA; 1981 Jul; 246(3):257-61. PubMed ID: 6787220
    [No Abstract]   [Full Text] [Related]  

  • 14. [Prevention of rat galactose cataract with topical aldose reductase inhibitor, E-1008].
    Tasaka H; Akagi Y; Yoshikawa T; Ikebe H; Takahashi Y; Chamoto K; Miyamoto Y; Terubayashi H
    Nippon Ganka Gakkai Zasshi; 1987 Feb; 91(2):246-53. PubMed ID: 3111200
    [No Abstract]   [Full Text] [Related]  

  • 15. Diabetic cataracts in animal models: prevention and reversibility with aldose reductase inhibitors.
    Kador PF; Akagi Y; Kinoshita JH
    Diabet Med; 1985 May; 2(3):194-6. PubMed ID: 2952419
    [No Abstract]   [Full Text] [Related]  

  • 16. Lens aldose reductase in diabetic and galactosemic cataracts.
    Parmar NS; Ghosh MN
    Indian J Physiol Pharmacol; 1981; 25(3):193-200. PubMed ID: 6795119
    [No Abstract]   [Full Text] [Related]  

  • 17. Study of aldose reductase inhibition in intact lenses by 13C nuclear magnetic resonance spectroscopy.
    Williams WF; Odom JD
    Science; 1986 Jul; 233(4760):223-5. PubMed ID: 3088727
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Inhibition of aldose reductase from the rat lens by flavonoids].
    Xie MZ; Shen ZF
    Yao Xue Xue Bao; 1986 Oct; 21(10):721-4. PubMed ID: 3107341
    [No Abstract]   [Full Text] [Related]  

  • 19. [Aldose-reductase inhibitors and cataract formation (author's transl)].
    Keller G; Leuenberger PM
    Klin Monbl Augenheilkd; 1980 Apr; 176(4):514-5. PubMed ID: 6775130
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Ponalrestat: a potent and selective inhibitor of bovine lens aldose reductase.
    Tuffin DP; Dingle A; Sennitt CM; Mirrlees DJ; Ward WH
    Prog Clin Biol Res; 1989; 290():221-35. PubMed ID: 2498899
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 8.